The idea of bringing the woolly mammoth back to life has shifted from science fiction to plausible reality. Colossal Biosciences, a biotechnology company based in Dallas, recently announced a massive breakthrough in their de-extinction project. Their team successfully derived induced pluripotent stem cells (iPSCs) from Asian elephants. This development is the critical foundation needed to edit elephant DNA and eventually create a cold-resistant mammal that functions exactly like a mammoth.
For years, the road to de-extinction was blocked by a specific biological hurdle: the inability to create elephant stem cells. While scientists have successfully generated stem cells for humans, mice, and rhinos, elephants proved much more difficult.
Colossal Biosciences announced that their team, led by Eriona Hysolli, finally cracked this code. They successfully reprogrammed skin cells from Asian elephants into an embryonic-like state. These induced pluripotent stem cells (iPSCs) have the ability to turn into any type of cell in the body. This is crucial for three main reasons:
The primary reason this took so long involves a gene called TP53. This gene is known as a “guardian of the genome” because it regulates cell division and prevents cancer. While humans have two copies of TP53, elephants have nearly 40 copies.
This massive redundancy makes elephants incredibly resistant to cancer, but it also makes their cells hyper-sensitive. When scientists previously tried to reprogram elephant cells into stem cells, the TP53 genes would detect the change as damage and cause the cells to self-destruct (apoptosis).
Colossal’s team found a way to chemically suppress the TP53 pathway just long enough to allow the transformation into stem cells to occur. Once the cells stabilized, they returned the TP53 function to normal. This delicate chemical balancing act was the key to their success.
Now that the stem cells exist, the timeline for seeing a “mammoth” has become more concrete. Colossal Biosciences has set an ambitious target to have their first calves born by 2028. The creature will not be a genetic clone of a mammoth that lived 4,000 years ago. Instead, it will be an Asian elephant with a genome edited to carry the physical and behavioral traits of a woolly mammoth.
The process involves several high-tech steps utilizing CRISPR gene-editing technology:
While the mammoth gets the headlines, this technology has immediate benefits for living elephants. The Asian elephant is an endangered species facing a deadly threat known as Elephant Endotheliotropic Herpesvirus (EEHV). This hemorrhagic disease is the leading cause of death for young Asian elephants in captivity and the wild.
Because Colossal now has functioning elephant stem cells, they can create elephant blood cells in the lab to study EEHV. This allows researchers to test treatments and vaccines rapidly. Without these stem cells, testing potential cures was slow and dangerous. The de-extinction technology is directly funding and fueling tools to save the species that are still here.
The goal of this project extends beyond simply seeing a prehistoric giant. The driving force is a concept called “rewilding” the Arctic.
Thousands of years ago, the Mammoth Steppe was a grassland ecosystem. Mammoths acted as natural engineers. They knocked down trees and trampled the snow. This behavior is vital for the permafrost.
When heavy snow sits on the ground, it acts as an insulator, trapping heat in the earth. By trampling the snow, mammoths allowed the extreme Arctic cold to penetrate deep into the ground, keeping the permafrost frozen.
Current climate models suggest that thawing permafrost releases massive amounts of methane and carbon. Proponents of the project, including Colossal co-founder George Church, argue that reintroducing cold-tolerant megafauna could help restore the grasslands and keep the carbon locked underground.
Is the animal a clone of a real mammoth? No. It is a functional mammoth. It will be an Asian elephant with specific genetic edits that give it the biological traits of a woolly mammoth (hair, fat, cold resistance). It is a hybrid designed to fill the mammoth’s ecological niche.
When will the first mammoth be born? Colossal Biosciences has stated their goal is to have the first calves by 2028. However, scientific timelines often shift depending on the success of gestation and embryo development.
Will this hurt Asian elephants? The creation of stem cells actually helps Asian elephants by allowing scientists to study diseases like EEHV. However, ethical concerns remain regarding the use of surrogates. Colossal is investing heavily in artificial womb technology to avoid putting strain on female Asian elephants.
Where will the mammoths live? The long-term plan is to release them into the Arctic regions of Northern America and Northern Asia. However, the first generations will likely be raised in controlled, zoo-like environments to ensure their health and study their behaviors.